LL-37
Cathelicidin antimicrobial peptide studied in immune research.
Evidence Level
Moderate
Research Type
/ System Mapping
Where this compound appears in research pathways
Research-only note: This mapping is educational and does not represent a treatment protocol.
/ 01
Overview
Cathelicidin antimicrobial peptide studied in immune research.
/ 02
Mechanism of Action
Studied for antimicrobial activity and immune modulation.
/ 03
Research Applications
Antimicrobial and inflammatory pathway research.
Studied for, research explores, preclinical models suggest, clinical studies have investigated.
/ 04
Studied Research Contexts
/ 05
Studied Research Dosing Ranges
Limited public data on dosing ranges across research models.
/ 06
Potential Adverse Effects Reported in Research
Adverse effect data is limited. Many compounds in this database lack human safety profiles.
/ 07
Mechanism Deep Dive
LL-37 is the only human cathelicidin antimicrobial peptide. Research describes broad-spectrum antimicrobial activity, biofilm modulation, immune cell signaling, and roles in inflammation and wound-healing biology.
/ 08
Pathway Role
Sits within innate immunity and antimicrobial defense pathways, with crosstalk into inflammation and wound-healing signaling.
/ 09
Biological Targets
/ 10
Research Applications
- Antimicrobial activity research
- Wound healing models
- Inflammation modulation research
- Biofilm research
/ 11
Evidence Summary
Moderate mechanistic and preclinical literature. Controlled human therapeutic outcome data is limited.
Evidence Level Rationale
Rated moderate based on consistency of mechanistic findings across antimicrobial and immune model systems.
/ 12
Research Observation Timeline
Early Signal Window
Antimicrobial and signaling effects within hours in vitro
Primary Study Window
Days to weeks in immune and wound-model studies
Endpoint Type
Antimicrobial, immune, and wound-repair endpoints
Evidence Strength
Moderate mechanistic / preclinical
/ 13
Safety & Unknowns
Systemic human use is not well-characterized. Off-target immune and inflammatory effects are open research questions.
/ 14
Research Limitations
Translation from mechanistic and wound-model data to general human therapeutic timelines is not established.
/ 15
References
References are being curated from peer-reviewed literature.
/ 07
Evidence Score
Overall Research Confidence
Moderate
Reflects breadth of mechanism, study type, and reproducibility across research literature.
/ 08
Related Peptides
GHK-Cu
Copper-binding tripeptide studied in regenerative biology.
KPV
Tripeptide fragment of α-MSH studied for inflammatory modulation.
Epitalon
Tetrapeptide studied in telomerase/aging research.
Appears in pathways
For research and educational purposes only.
Not medical advice. Not intended to diagnose, treat, cure, or prevent disease. Compounds discussed may not be approved for human use. Any dosing information shown describes ranges studied in research settings — never a recommendation.